Developmental Effects of von Hippel-Lindau Gene Deficiency

Annals of Neurology

Volumn 55, Issue 5, 2004, Pages 721-728

  Vortmeyer, Alexander O ^a   Yuan, Quingyang ^a   Lee, Youn Soo ^a   Zhuang, Zhengping ^a   Oldfield, Edward H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER LOCALIZATION; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FAMILY HISTORY; GENE; GENE DELETION; GENE INACTIVATION; GENETIC ANALYSIS; GENETIC DISORDER; HEMANGIOBLASTOMA; HISTOGENESIS; HUMAN; HUMAN TISSUE; NERVE ROOT; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPINAL CORD; TOPOGRAPHY; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE; VON HIPPEL LINDAU GENE;

ADULT; AGED; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; HEMANGIOBLASTOMA; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MESODERM; MIDDLE AGED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 2142811530     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20090     Document Type: Article

References (17)

1. Spence AM, Rubinstein LJ. Cerebellar capillary hemangioblastoma-its histogenesis studied by organ culture and electron microscopy. Cancer 1975;35:326-341.
2. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 1995;55:1358-1364.
3. Hatva E, Bohling T, Jaaskelainen J, et al. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 1996;148:763-775.
4. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 1997;28:540-543.
5. Choyke PL, Glenn GM, Walther MM, et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. Am J Roentgenol 1992;159:1229-1234.
6. Zhuang Z, Bertheau P, Emmert-Buck MR, et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions less than 1 mm in size. Am J Pathol 1995;146:620-625.
7. Mandriota SJ, Turner KJ, Davies DR, et al. HIF activation identifies early lesions in VHL kidneys. Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 2002;1:459-468.
8. Kim W, Kaelin WG. The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. Curr Opin Genet Dev 2003;13:55-60.
9. Maxwell PH. Oxygen homeostasis and cancer: insights from a rare disease. Clin Med 2002;2:356-362.
10. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003;98:82-94.
11. Becker I, Paulus W, Roggendorf W. Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study. Am J Pathol 1989;134:271-275.
12. Lonser RR, Wait SD, Butman JA, et al. Surgical management of lumbosacral nerve root hemangioblastomas in von Hippel-Lindau syndrome. J Neurosurg 2003;99:64-69.
13. Lindau A. Discussion on vascular tumors of the brain and spinal cord. Proc R Soc Med 1931;24:363-370.
14. Vortmeyer AO, Frank S, Jeong SY, et al. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res 2003;63:7051-7055.
15. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-1320.
16. Knudson AG Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-1443.
17. Stein AA, Schilp AO, Whitfield RD. The histogenesis of hemangioblastoma of the brain. J Neurosurg 1960;17:751-761.